Th17 response promotes angiotensin II-induced atherosclerosis

Medical Hypotheses

Volumn 76, Issue 4, 2011, Pages 593-595

  Liu, Xiao Hong ^a   Ji, Qing wei ^b   Huang, Ying ^c   Zeng, Qiu tang ^b  

^a SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CHEMOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE; CELL DIFFERENTIATION; CELL MIGRATION; CELLULAR IMMUNITY; CHOLESTEROL BLOOD LEVEL; DISEASE COURSE; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; INFLAMMATION; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOGENESIS; REGULATORY T LYMPHOCYTE; TH17 CELL; VASCULITIS;

ANGIOTENSIN II; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; HUMANS; INTERLEUKIN-18; MICE; MICE, MUTANT STRAINS; TH17 CELLS;

ANIMALIA;

EID: 79952314823     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.01.008     Document Type: Article

References (24)

1. Robertson A.K., Hansson G.K. T cells in atherogenesis: for better or for worse?. Arterioscler Thromb Vasc Biol 2006, 26:2421-2432.
2. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone I definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
3. Parronchi P., Macchia D., Piccinni M.P., et al. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991, 88:4538-4542.
4. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
5. Harvey EJ, Ramji DP. Interferon-gamma and atherosclerosis: pro- or anti-atherogenic? Cardiovasc Res 2005;67:11-20.
6. Harrington L.E., Hatton R.D., Mangan P.R., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132.
7. Park H., Li Z., Yang X.O., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141.
8. Csiszar A., Ungvari Z. Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease. Med Hypotheses 2004, 63:696-698.
9. Hashmi S., Zeng Q.T. Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease. Coron Artery Dis 2006, 17:699-706.
10. Cheng X., Yu X., Ding Y.J., et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008, 127:89-97.
11. Eid R.E., Rao D.A., Zhou J., et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009, 119:1424-1432.
12. Song L., Schindler C. IL-6 and the acute phase response in murine atherosclerosis. Atherosclerosis 2004, 177:43-51.
13. Huber S.A., Sakkinen P., Conze D., Hardin N., Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 1999, 19:2364-2367.
14. Xie J.J., Wang J., Tang T.T., et al. The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice. Cytokine 2010, 49:185-193.
15. Erbel C., Chen L., Bea F., et al. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J Immunol 2009, 183:8167-8175.
16. van Es T., van Puijvelde G.H., Ramos O.H., et al. Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. Biochem Biophys Res Commun 2009, 388:261-265.
17. Mallat Z., Corbaz A., Scoazec A., et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 2001, 89:E41-E45.
18. Elhage R., Jawien J., Rudling M., et al. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 2003, 59:234-240.
19. Pejnovic N., Vratimos A., Lee S.H., et al. Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet. Mol Immunol 2009, 47:37-45.
20. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86:515-581.
21. Nataraj C., Oliverio M.I., Mannon R.B., et al. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest 1999, 104:1693-1701.
22. Shao J., Nangaku M., Miyata T., et al. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 2003, 42:31-38.
23. Mazzolai L., Duchosal M.A., Korber M., et al. Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice. Hypertension 2004, 44:277-282.
24. Madhur M.S., Lob H.E., McCann L.A., et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010, 55:500-507.